Watchlist Price Alert

Coeptis Therapeutics Inc. (COEP)

NASDAQ: COEP · Real-Time Price · USD

7.84

0.06 (0.77%)

At close: Jun 30, 2025, 3:59 PM

Coeptis Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-10.88M	-21.27M	-37.57M	-13.45M	-9.16M	-2.23K
Depreciation & Amortization	1.04M	1M	1M	447.41K	323.43K	n/a
Stock-Based Compensation	1.1M	477.5K	n/a	1.9M	n/a	n/a
Other Working Capital	259.42K	432.88K	-507.19K	-1M	472.68K	450.00
Other Non-Cash Items	2.21M	10.79M	33.25M	4.26M	3.03M	-88.28K
Deferred Income Tax	n/a	n/a	n/a	5.34M	n/a	n/a
Change in Working Capital	-125.26K	1.76M	-550.34K	-2.98M	2.66M	450.00
Operating Cash Flow	-6.65M	-7.24M	-3.88M	-4.49M	-3.14M	-90.07K
Capital Expenditures	n/a	4.00	n/a	-1.75M	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-75.75M	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	-1.75M	-75.75M	n/a
Debt Repayment	1.2M	-575K	-2.42M	-1.62M	1.83M	n/a
Common Stock Repurchased	n/a	n/a	n/a	-247.16K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	500K	200K	4.63M	-50.9K	n/a	90.57K
Financial Cash Flow	5.71M	4.92M	5.49M	8.22M	2.9M	90.57K
Net Cash Flow	-936.25K	-2.32M	1.61M	1.98M	-237.12K	505.00
Free Cash Flow	-6.65M	-7.24M	-3.88M	-6.24M	-3.14M	-90.07K